Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Correction: Pharma Equity Group's subsidiary, Reponex Pharmaceuticals A/S, receives regulatory approval to initiate pivotal clinical trial with RNX-011 for life-threatening peritonitis
-
Form 8.3 - JTC Plc
-
Allego steps beyond charging: entering extended mobility services
-
Huhtamäki Oyj announces indicative results of voluntary tender offer for its notes maturing in 2027
-
Dimensional Fund Advisors Ltd. : Form 8.3 - UNITE GROUP PLC/THE - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - SPIRENT COMMUNICATIONS PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - EMPIRIC STUDENT PROPERTY PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DALATA HOTEL GROUP PLC - Ordinary Shares
-
Himax to Debut Game-Changing Proprietary Tcon Featuring Local Dimming and Industry-First Full-Area Selectable Local Dewarping for Next-Generation Automotive Displays
-
Form 8.3 - Dowlais Group plc
-
Man Group PLC : Form 8.3 - Spectris plc
-
Man Group PLC : Form 8.3 - Dowlais Group plc
-
Form 8.3 - Renold plc
-
Subsea7 awarded cable installation contract in Taiwan
-
CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES
-
UAB “Atsinaujinančios energetikos investicijos“ publishes interim financial statements for the 6-month period of 2025
-
AS Pro Kapital Grupp acquired an additional stake in an Italian real estate company
-
Electric Hydrogen Strengthens European Operations with Appointment of General Manager
-
OMass Therapeutics Enters into Exclusive Collaboration and License Agreement with Genentech to Develop and Commercialize Therapies for Inflammatory Bowel Disease
-
Composition of Suominen's Nomination Board
-
Transactions in connection with share buyback programme
-
SCOR announces the launch of a cash tender offer and its intention to issue new subordinated notes
-
Novaremed Announces Completion of All Patient Visits in NIH-Funded Phase 2b Trial of Non-Opioid Nispomeben for Treating Chronic Pain Associated with Diabetic Peripheral Neuropathy
-
Cegedim: shares transferred to trading on Euronext Growth as of September 4, 2025
-
Rexel: REXEL LAUNCHES A SENIOR NOTES OFFERING FOR A NOMINAL AMOUNT OF €400 MILLION
-
Correction: Falcon Oil & Gas Ltd. - Approval granted by Northern Territory Government for the Beneficial Use of Gas agreement
-
Correction: Falcon Oil & Gas Ltd. - Approval granted by Northern Territory Government for the Beneficial Use of Gas agreement
-
Coloplast A/S - Coloplast presents new 5-year strategy, Impact4
-
Falcon Oil & Gas Ltd. - Approval granted by Northern Territory Government for the Beneficial Use of Gas agreement
-
Pulsar Helium Announces Proposed Acquisition of Major Minnesota Land Position to the West of Topaz Project
-
Coloplast A/S - Announcement no. 07/2025 - Coloplast announces new financial ambition towards 2030
-
Equinor ASA: Share buy-back – third tranche for 2025
-
Scatec signs 15-year PPA for 130 MW solar plant in Colombia
-
Falcon Oil & Gas Ltd. - Approval granted by Northern Territory Government for the Beneficial Use of Gas agreement
-
FIRST PATIENT DOSED IN CITRYLL’S PHASE IIA TRIAL EVALUATING CIT-013 IN RHEUMATOID ARTHRITIS
-
CHARM Therapeutics raises $80 million in Series B financing to advance development of best-in-class menin inhibitor for AML
-
NBPE - Transaction in Own Shares
-
Transaction in own shares
-
Progress on share buyback programme
-
ONWARD Medical Demonstrates Commercial Traction and Advances Pipeline in the First Half of 2025
-
Sampo plc’s share buybacks 1 September 2025
-
BW Offshore: Ex dividend USD 0.0625 today
-
Moody's upgraded LHV Group's senior ratings
-
Start of Day Message
-
Pharming Group appoints Kenneth Lynard as Chief Financial Officer
-
Dennis de Vreede to step down as CFO at 2026 AGM
-
Weekly progress on share repurchase program to cover share plans and reduce capital
-
Ackermans & van Haaren commits 20 million US dollars to the second fund of Venturi Partners
-
Definitive Feasibility Study Results and Reserves Upgrade Confirms Minim Martap as a Tier-One Bauxite Operation
-
CGTN: China's Global Governance Initiative aims to inject greater stability into world governance
